Falling for five consecutive days, Aurora Cannabis ended the session at 58.58 cents (down 5.36%)

A quick look at today: Aurora Cannabis shed 5.36%, falling to 58.58 cents.

United States Producer Price Index released earlier showed a marked improvement to 0.2% from the preceding data of -0.4%, but fell short of the 0.3% figure forecast by a consensus of market analysts. Initial Jobless Claims in United States fell short of market expectations (245,000) with a reading of 264,000, continuing the decline from the previous figure of 242,000.

This down-slide takes place while positive United States macroeconomics indicators data was published earlier – United States Crude Oil Inventories improved upon its previous reading of -1.28 million with a new data release of 2.95 million.

Technical analysis of Aurora Cannabis's past price action reveals multiple support and resistance levels: Aurora Cannabis Inc. could begin to recover as it approaches significant support, now 2 cents away from 56.7733 cents. Dipping below could be an indication that further losses are ahead. Trend-focused traders would be interested to note that Aurora Cannabis made an initial break below its 21 day Simple Moving Average at 61.8548 cents, a possible indication of a forthcoming negative trend. According to asset volatility analysis, Aurora Cannabis's lower Bollinger Band® is at 55.9649 cents, indicating that the asset has overextended to the downside and could, therefore, bounce back as buyers look for bargains.

Overall, the technical outlook suggests Aurora Cannabis is likely to remain muted for the immediate future, with no clear-cut direction.

Aurora Cannabis was not the only decliner in the health care sector; Pfizer went down to $37.58, losing 0.82% after it closed at $37.89 today. Amgen stumbles 0.78% today to close at $234.11.

On the other hand, positive performances could be seen by looking at other health care stocks as Bristol-Myers Squibb Company traded at $69.08 after closing today's trading day at $68.49 (up 0.86%).

11 months ago the Canadian cannabis producer reached a significant high of $3.09 but has consequently lost 79.97% since then.